SEARCH

SEARCH BY CITATION

REFERENCES

  • AnkleyGT,DastonGP,DegitzSJ,DenslowND,HokeRA,KennedySW,MiracleAL,PerkinsEJ,SnapeJ,TillittDE,TylerCR,VersteegD. 2006.Toxigenomics in regulatory ecotoxicology. Environ Sci Technol 40:40554065.
  • ATSDR. 2007.Toxicological Profile for Arsenic.Atlanta, GA: United States Department of Health and Human Services. Public Health Service. Agency for Toxic Substances and Disease Registry. Available at: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=22&tid=3.
  • BednarAJ,KirganRA,JonesWT. 2009.Comparison of standard and reaction cell inductively coupled plasma mass spectrometry in the determination of chromium and selenium species by HPLC-ICP-MS. Anal Chem Acta 632:2734.
  • BenjaminiY,HochbergY. 1995.Controlling the false discovery rate: A practical and powerful approach to multiple testing.J R Stat Soc Ser B 57 760:289300.
  • BentonMA,RagerJE,SmeesterL,FryRC. 2011.Comparative genomic analyses identify common molecular pathways modulated upon exposure to low doses of arsenic and cadmium.BMC Genomics 12:173183.
  • BranchS,EbdonL,O'NeillP. 1994.Determination of arsenic species in fish by directly coupled high-performance liquid chromatography-inductively coupled plasma mass spectrometry.J Anal At Spectrom 9:3337.
  • CalabreseEJ,BachmannKA,BailerAJ,BolgerPM,BorakJ,CaiL,CedergreenN,CherianMG,ChiuehCC,ClarksonTW,CookRR,DiamondDM,DoolittleDJ,DoratoMA,DukeSO,FeinendegenL,GardnerDE,HartRW,HastingsKL,HayesAW,HoffmannGR,IvesJA,JaworowskiZ,JohnsonTE,JonasWB,KaminskiNE,KellerJG,KlaunigJE,KnudsenTB,KozumboWJ,LettieriT,LiuSZ,MaisseuA,MaynardKI,MasoroEJ,McClellanRO,MehendaleHM,MothersillC,NewlinDB,NiggHN,OehmeFW,PhalenRF,PhilbertMA,RattanSI,RiviereJE,RodricksJ,SapolskyRM,ScottBR,SeymourC,SinclairDA,Smith-SonnebornJ,SnowET,SpearL,StevensonDE,ThomasY,TubianaM,WilliamsGM,MattsonMP. 2007.Biological stress response terminology: integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework.Toxicol Appl Pharmacol 222:122128.
  • ChiouHY,ChiouST,HsuYH,ChouYL,TsengCH,WeiML,ChenCJ. 2001.Incidence of transitional cell carcinoma and arsenic in drinking water: A follow-up study of 8,102 residents in an arseniasis-endemic area of northeastern Taiwan.Am J Epidemiol 153:411418.
  • ChouchaneS,SnowET. 2001.In vitro effect of arsenical compounds on glutathione-related enzymes.Chem Res Toxicol 14:517522.
  • ClewellHJ,ThomasRS,KenyonEM,HughesMF,AdairBM,GentryPR,YagerJW. 2011.Concentration- and time-dependent genomic changes in the mouse urinary bladder following exposure to arsenate in drinking water for up to 12 weeks.Toxicol Sci 123:421432.
  • CohenSM,ArnoldLL,EldanM,LewisAS,BeckBD. 2006.Methylated arsenicals: The implications of metabolism and carcinogenicity studies in rodents to human risk assessment.Crit Rev Toxicol 36:99133.
  • CohenSM,OhnishiT,ArnoldLL,LeXC. 2007.Arsenic-induced bladder cancer in an animal model.Toxicol Appl Pharmacol 222:258263.
  • DingW,HudsonLG,LiuKJ. 2005.Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes.Mol Cell Biochem 279:105112.
  • EbleJN, SauterG, EpsteinJI, SesterhennIA, editors. 2004.WHO Classification of Tumours: Tumours of the Urinary System and Male Genital Organs.Lyon, France: International Agency for Research on Cancer, IARC Press.
  • EFSA. 2009.Scientific opinion on arsenic in food. EFSA Panel on Contaminants in Food Chain (CONTAM). European Food Safety Authority, Parma, Italy.EFSA J 7:1351.
  • Escudero-LourdesC,MedeirosMK,Cardenas-GonzalezMC,WnekSM,GandolfiJA. 2010.Low level exposure to monomethylarsonous acid induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model.Toxicol Appl Pharmacol 244:162173.
  • FloraSJ. 2011.Arsenic-induced oxidative stress and its reversibility.Free Radic Biol Med 51:257281.
  • GentryPR,McDonaldTB,SullivanDE,ShippAM,YagerJW,ClewellHJ III. 2010.Analysis of genomic dose-response information on arsenic to inform key events in a mode of action for carcinogenicity.Environ Mol Mutagen 51:114. Review.
  • GriffithOW. 1980.Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine.Anal Biochem 106:207212.
  • HartwigA,AsnaussM,EhlebenI,HerzerU,KostelacD,PelzerA,SchwerdtleB,BurkleA. 2002.Interference by toxic metal ions with DNA repair processes and cell cycle control: Molecular mechanisms.Environ Health Perspect Suppl 5:797799.
  • HeitkemperDT,VelaNP,StewartKR,WestphalCS. 2001.Determination of total and speciated arsenic in rice by ion chromatography and inductively coupled plasma mass spectrometry.J Anal At Spectrom 16:299306.
  • HelbockHJ,BeckmanKB,AmesBN. 1999.8-Hydroxy-deoxyguanosine and 8-hydroxyguanine as biomarkers of oxidative DNA damage.Methods Enzymol 300:156166.
  • HuY,JinX,SnowET. 2002.Effect of arsenic on transcription factor AP-1 and Nf-kappaB DNA binding activity and related gene expression.Toxicol Lett 133:3345.
  • IARC. 2012.Review of Human Carcinogens. Part C. Arsenic, Metals, Fibres and Dusts. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 100. Lyon, France: International Agency for Research on Cancer. pp 79.
  • IrizarryRA,BolstadBM,CollinF,CopeLM,HobbsB,SpeedTP. 2003.Summaries of Affymetrix GeneChip probe level data.Nucleic Acids Res 31:e15.
  • KaragasMR,TostesonTD,MorrisJS,DemidenkoE,MottLA,HeaneyJ,SchnedA. 2004.Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.Cancer Causes Control 15:465472.
  • KasaiH. 1997.Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis.Mutat Res 387:147163.
  • KennedyRE,KernsRT,KongX,ArcherKJ,MilesMF. 2006.SScore: An R package for detecting differential gene expression without gene expression summaries.Bioinformatics 22:12721274.
  • KenyonEM,HughesMF,AdairBM,HighfillJM,CreceliusEA,ClewellHJ,YagerJW. 2008.Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water.Toxicol Appl Pharmacol 232:448455.
  • KernsRT,ZhangL,MilesMF. 2003.Application of S-score algorithm for analysis of oligonucleotide microarrays.Methods 31:274281.
  • KetavarupuS,YathavakillaV,FrickeM,CreedPA,HeitkemperDT,ShockeyNV,SchegelC,CarusoJA. CreedJT. 2008.Arsenic speciation and identification of monomethylarsonous acid and monomethylthioarsonic acid in a complex matrix.Anal Chem 80:775782.
  • KitchinKT. 2001.Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites.Toxicol Appl Pharmacol 172:249261.
  • KitchinKT,AhmadS. 2003.Oxidative stress as a possible mode of action for arsenic carcinogenesis.Toxicol Lett 137:313.
  • KitchinKT,WallaceK. 2005.Arsenite binding to synthetic peptides based on the Zn finger region and the estrogen binding region of the human estrogen receptor-alpha.Toxicol Appl Pharmacol 206:6672.
  • KitchinKT,WallaceK. 2008.Evidence against the nuclear in situ binding of arsenicals—oxidative stress theory of arsenic carcinogenesis.Toxicol Appl Pharmacol 232:252257.
  • KleinCB,LeszczynskaJ,HickeyC,RossmanTG. 2007.Further evidence against a direct genotoxic mode of action for arsenic-induced cancer.Toxicol Appl Pharmacol 222:289–297.
  • KongXT,DengFM,HuP,LiangFX,ZhouG,AuerbachAB,GenieserN,NelsonPK,RobbinsES,ShapiroE,KacharB,SunTT. 2004.Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases.J Cell Biol 167:11951204.
  • Lerda, D. 1994.Sister chromatid exchange (Sce) among individuals chronically exposed to arsenic in drinking water.Mutat Res 312:111120.
  • LiJH,RossmanTG. 1989.Inhibition of DNA ligase activity by arsenite: A possible mechanism of its comutagenesis.Mol Toxicol 2:19.
  • LiuQ,ZjangH,SmeesterL,ZouF,KesicM,JaspersI,PiJ,FryRC. 2010.The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel.BMC Med Genomics 3:37.
  • MandalBK,OgraY,SuzukiKT. 2001.Identification of dimethylarsenious and monomethylarsonous acids in human urine of the arsenic-affected areas in west Bengal, India.Chem Res Toxicol 14:371378.
  • MeiN,KunugitaN,HiranoT,KasaiH. 2002.Acute arsenite-induced 8-hydroxyguanine is associated with inhibition of repair activity in cultured human cells.Biochem Biophys Res Commun 297:924930.
  • MoJ,XiaY,NingZ,WadeTJ,MumfordJ. 2009.Elevated ERCC1 gene expression in blood cells associated with exposure to arsenic from drinking water in Inner Mongolia.Anticancer Res 29:32533259.
  • NRC-NAS. 2007.Toxicity Testing in the 21st Century: A Vision and a Strategy.Washington, DC: National Research Council, National Academy of Sciences.
  • PetzoldtJL,LeighIM,DuffyPG,SextonC. 1995.Immortalization of human urothelial cells.Urol Res 23:377380.
  • PiJ,DiwayBA,SunY,LiuJ,QuW,HeY,StybloM,WaalkesMP. 2008.Arsenic-induced malignant transformation of human keratinocytes: Involvement of Nrf2.Free Radic Biol Med 45:651658.
  • QinX-J,HudsonLG,LiuW,DingW,CooperKL,LiuKJ. 2008.Dual actions involved in arsenite-induced oxidative DNA damage.Chem Res Toxicol 21:18061813.
  • The R Core Team. 2012.R: A Language and Environment for Statistical Computing.Vienna, Austria: R Foundation for Statistical Computing. ISBN 3-900051-07-0. Available at: http://www.R- project.org.
  • RoopDR,Hawley-NelsonP,ChengCK,YuspaSH. 1983.Keratin gene expression in mouse epidermis and cultured epidermal cells.Proc Natl Acad Sci USA 80:716720.
  • RossmanTG. 2003.Mechanisms of arsenic carcinogenesis: an integrated approach.Mutat Res 533:3765.
  • SnowET,SykoraP,DurhamTR,KleinCB. 2005.Arsenic, mode of action at biologically plausible low doses: What are the implications for low dose cancer risk?.Toxicol Appl Pharmacol 207 (2 Suppl):557564.
  • SouthgateJ,HuttonKA,ThomasDF,TrejdosiewiczLK. 1994.Normal human urothelial cells in vitro: proliferation and induction of stratification.Lab Invest 71:583594.
  • SouthgateJ,VarleyCL,GarthwaiteMAE,HinleyJ,MarshF,StahlschmidtJ,TrejdosiewiczLK,EardleyI. 2007.Differentiation potential of urothelium from patients with benign bladder dysfunction.Br J Urol 99:15061516.
  • StraifK,Benbrahim-TallaaL,BaanR,GrosseY,SecretanBE,GhissassiF,BourardV,GuhaN,FreemanC,GalichetL,CoglianoV, the Working Group WHO/IAEC. 2009.A review of human carcinogens. Part C. Metals, arsenic, dust and fibres.Lancet Oncol 10:453454.
  • SykoraP,SnowET. 2008.Modulation of DNA polymerase beta-dependent base excision repair in cultured human cells after low dose exposure to arsenite.Toxicol Appl Pharmacol 228:385394.
  • TokarEJ,Benbrahim-TallaaL,WardJM,LunnR,SamsRLII,WaalkesMP. 2010.Cancer in experimental animals exposed to arsenic and arsenic compounds.Crit Rev Toxicol 40:912927.
  • TokarEJ,DiwanBA,WardJM,DelkerDA,WaalkesMP. 2011.Carcinogenic effects of whole life exposure to inorganic arsenic in CD1 mice.Toxicol Sci 119:7383.
  • TukeyJW,CimineraJL,HeyseJF. 1985.Testing the statistical certainty of a response to increasing doses of a drug.Biometrics 41:295301.
  • VarleyCL,StahlschmidtJ,LeeW-C,HolderJ,DiggleC,SelbyPJ,TrejdosiewiczLK,SouthgateJ. 2003.Role of PPARγ and EGFR signaling in the urothelial terminal differentiation programme.J Cell Sci 117:20292036.
  • WangX-J,SunZ,ChenW,EblinKE,GandolfiJA,ZhangDD. 2007a. Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity.Toxicol Appl Pharmacol 225:206213.
  • WangR-Y,HsuY-L,ChangL-F,JiangS-J. 2007b. Speciation analysis of arsenic and selenium compounds in environmental and biological samples by ion-chromatography-inductively coupled plasma dynamic reaction cell mass spectrometer.Anal Chem Acta 590:239244.
  • WeiM,ArnoldLL,CanoM,CohenSM. 2005.Effect of co-administration of antioxidants and arsenicals on the rat urinary bladder epithelium.Toxicol Sci 83:237245.
  • WnekSM,MedeirosMK,EblinKE,GandolfiAJ. 2009.Persistence of DNA damage following exposure of human bladder cells to chronic monomethylarsonous acid.Toxicol Appl Pharmacol 241:202209.
  • WnekSM,KuhlmanCL,CamarilloJM,MedeirosMK,LiuKJ,LauSS,GandolfiAJ. 2011.Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly (ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells.Toxicol Appl Pharmacol 257:113.
  • YagerJW,WienckeJK. 1993.Enhancement of chromosomal damage by arsenic: Implications for mechanism.Environ Health Perspect 101(Suppl 3):7982.
  • YagerJW,WienckeJK. 1997.Inhibition of poly (ADP-ribose) polymerase by arsenite.Mutat Res 386:345351.
  • YokohiraM,ArnoldLL,PenningtonKL,SuzukiS,Kakiuchi-KiyotaS,Herbin-DavisK,ThomasDJ,CohenSM. 2011.Effect of sodium arsenite dose administered in the drinking water on the urinary bladder epithelium of female arsenic (+3 oxidation state) methyltransferase knockout mice.Toxicol Sci 121:257266.
  • ZhangL,WangL,RavindranathanA,MilesMF. 2002.A new algorithm for analysis of oligonucleotide arrays: Application to expression profiling in mouse brain regions.J Mol Biol 317:225235.
  • ZhouX,SunX,CooperKL,WangF,LiuKJ,HudsonLG. 2011.Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs.J Biol Chem 286:2285522863.